Keyoumars Ashkan

12.3k total citations · 2 hit papers
254 papers, 7.1k citations indexed

About

Keyoumars Ashkan is a scholar working on Neurology, Cellular and Molecular Neuroscience and Genetics. According to data from OpenAlex, Keyoumars Ashkan has authored 254 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 149 papers in Neurology, 70 papers in Cellular and Molecular Neuroscience and 56 papers in Genetics. Recurrent topics in Keyoumars Ashkan's work include Neurological disorders and treatments (122 papers), Parkinson's Disease Mechanisms and Treatments (80 papers) and Glioma Diagnosis and Treatment (55 papers). Keyoumars Ashkan is often cited by papers focused on Neurological disorders and treatments (122 papers), Parkinson's Disease Mechanisms and Treatments (80 papers) and Glioma Diagnosis and Treatment (55 papers). Keyoumars Ashkan collaborates with scholars based in United Kingdom, United States and Germany. Keyoumars Ashkan's co-authors include Peter Brown, Ludvic Zrinzo, James Dooley, Aftab Ala, Michael L. Schilsky, Ann P. Walker, Patricia Limousin, Thomas Foltynie, Tipu Z. Aziz and Alexander L. Green and has published in prestigious journals such as The Lancet, Nature Communications and Journal of Neuroscience.

In The Last Decade

Keyoumars Ashkan

239 papers receiving 7.0k citations

Hit Papers

Adaptive deep brain stimulation in advanced Parkinson dis... 2007 2026 2013 2019 2013 2007 250 500 750

Peers

Keyoumars Ashkan
Comparison fields: 5 of 152
  • Neurology 3.9k
  • Cellular and Molecular Neuroscience 2.4k
  • Cognitive Neuroscience 1.5k
  • Neurology 870
  • Nutrition and Dietetics 700
Replace Peter Hedera with:
Peter Hedera United States
Vladimir Kostić Serbia
Achim Berthele Germany
Georg Becker Germany
David Devos France
Saburo Sakoda Japan
Susanne A. Schneider Germany
Hideki Mochizuki Japan
Ole‐Bjørn Tysnes Norway
Phil Hyu Lee South Korea
Peter Hedera United States View profile →
Citations per field, relative to Keyoumars Ashkan
Keyoumars Ashkan · 1×
Citations per year, relative to Keyoumars Ashkan
Keyoumars Ashkan · 1×

Countries citing papers authored by Keyoumars Ashkan

Since Specialization
Citations

This map shows the geographic impact of Keyoumars Ashkan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keyoumars Ashkan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keyoumars Ashkan more than expected).

Fields of papers citing papers by Keyoumars Ashkan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keyoumars Ashkan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keyoumars Ashkan. The network helps show where Keyoumars Ashkan may publish in the future.

Co-authorship network of co-authors of Keyoumars Ashkan

This figure shows the co-authorship network connecting the top 25 collaborators of Keyoumars Ashkan. A scholar is included among the top collaborators of Keyoumars Ashkan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keyoumars Ashkan. Keyoumars Ashkan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 2
2 1
3 0
4 3
5 1
6 0
7 1
8 3
9 0
10 1
11 0
12 2
13 23
14 34
15 69
16 51
17 2
18
Dual targeting NG2 and GD3A using Mab-Zap immunotoxin results in reduced glioma cell viability in vitro.
12
19
Expression of the chondroitin sulphate proteoglycan, NG2, in paediatric brain tumors.
7
20 4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026